Actinium Pharmaceuticals Inc (ATNM)
7.38
+0.51
(+7.42%)
USD |
NYAM |
Apr 29, 16:00
7.42
+0.04
(+0.54%)
Pre-Market: 20:00
Actinium Pharmaceuticals 1 Year Total Returns (Daily): -16.14% for April 29, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| April 29, 2024 | -16.14% |
| April 26, 2024 | -21.93% |
| April 25, 2024 | -26.29% |
| April 24, 2024 | -24.81% |
| April 23, 2024 | -25.16% |
| April 22, 2024 | -22.90% |
| April 19, 2024 | -25.30% |
| April 18, 2024 | -28.28% |
| April 17, 2024 | -21.96% |
| April 16, 2024 | -15.04% |
| April 15, 2024 | -7.35% |
| April 12, 2024 | 1.58% |
| April 11, 2024 | 0.11% |
| April 10, 2024 | -2.18% |
| April 09, 2024 | 0.00% |
| April 08, 2024 | 1.67% |
| April 05, 2024 | 9.53% |
| April 04, 2024 | 1.90% |
| April 03, 2024 | -3.91% |
| April 02, 2024 | -8.99% |
| April 01, 2024 | -9.42% |
| March 28, 2024 | -13.38% |
| March 27, 2024 | -12.56% |
| March 26, 2024 | -13.06% |
| March 25, 2024 | -7.17% |
| Date | Value |
|---|---|
| March 22, 2024 | 0.33% |
| March 21, 2024 | -3.39% |
| March 20, 2024 | -6.01% |
| March 19, 2024 | -11.53% |
| March 18, 2024 | -29.53% |
| March 15, 2024 | -27.73% |
| March 14, 2024 | -34.62% |
| March 13, 2024 | -24.89% |
| March 12, 2024 | -22.56% |
| March 11, 2024 | -18.68% |
| March 08, 2024 | -20.97% |
| March 07, 2024 | -23.44% |
| March 06, 2024 | -23.92% |
| March 05, 2024 | -23.30% |
| March 04, 2024 | -22.21% |
| March 01, 2024 | -18.32% |
| February 29, 2024 | -11.61% |
| February 28, 2024 | -13.89% |
| February 27, 2024 | -16.30% |
| February 26, 2024 | -10.26% |
| February 23, 2024 | -29.42% |
| February 22, 2024 | -22.80% |
| February 21, 2024 | -41.78% |
| February 20, 2024 | -49.56% |
| February 16, 2024 | -55.33% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-74.65%
Minimum
Oct 09 2019
170.9%
Maximum
Feb 17 2023
-4.40%
Average
-21.02%
Median
May 02 2022
1 Year Total Returns (Daily) Benchmarks
| Perspective Therapeutics Inc | 163.5% |
| Eli Lilly and Co | 87.77% |
| Cellectar Biosciences Inc | 101.3% |
| Outlook Therapeutics Inc | -56.67% |
| Bristol-Myers Squibb Co | -30.27% |